ProCE Banner Activity

Frequently Asked Questions on Emerging Antibody–Drug Conjugates in the Treatment of Advanced Non-Small-Cell Lung Cancer

Podcast Episodes
Listen to D. Ross Camidge, MD, PhD, and Joel W. Neal, MD, PhD, address questions from learners on investigational antibody–drug conjugates for advanced NSCLC.

Released: March 17, 2021

Expiration: March 16, 2022

Share

Faculty

D. Ross Camidge

D. Ross Camidge, MD, PhD

Professor of Medicine/Oncology
University of Colorado Cancer Center
Aurora, Colorado

Joel W. Neal

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Daiichi Sankyo, Inc.

Faculty Disclosure

Primary Author

D. Ross Camidge, MD, PhD

Professor of Medicine/Oncology
University of Colorado Cancer Center
Aurora, Colorado

Joel W. Neal, MD, PhD

Associate Professor of Medicine
Division of Oncology
Department of Medicine
Stanford University
Attending Physician
Stanford Cancer Institute
Palo Alto, California